Search

Jennifer Castriotta

Examiner (ID: 2648, Phone: (571)270-5279 , Office: P/3781 )

Most Active Art Unit
3733
Art Unit(s)
3781, 3733
Total Applications
769
Issued Applications
457
Pending Applications
68
Abandoned Applications
260

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10281638 [patent_doc_number] => 20150166635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'GPR88 MINI-PROMOTERS' [patent_app_type] => utility [patent_app_number] => 14/487982 [patent_app_country] => US [patent_app_date] => 2014-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9385 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487982 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/487982
GPR88 MINI-PROMOTERS Sep 15, 2014 Abandoned
Array ( [id] => 16923446 [patent_doc_number] => 11044896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use [patent_app_type] => utility [patent_app_number] => 15/021026 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 10216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021026 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/021026
T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use Sep 11, 2014 Issued
Array ( [id] => 9917213 [patent_doc_number] => 20150072418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'HCV GENOTYPE 4D REPLICONS' [patent_app_type] => utility [patent_app_number] => 14/459913 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9197 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459913 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/459913
HCV GENOTYPE 4D REPLICONS Aug 13, 2014 Abandoned
Array ( [id] => 16607160 [patent_doc_number] => 10908161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Corneal endothelial cell marker [patent_app_type] => utility [patent_app_number] => 14/908036 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28304 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908036 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/908036
Corneal endothelial cell marker Jul 27, 2014 Issued
Array ( [id] => 15606527 [patent_doc_number] => 10584313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere [patent_app_type] => utility [patent_app_number] => 14/338596 [patent_app_country] => US [patent_app_date] => 2014-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30480 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338596 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/338596
Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere Jul 22, 2014 Issued
Array ( [id] => 13635309 [patent_doc_number] => 09844605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-19 [patent_title] => Transgenic [patent_app_type] => utility [patent_app_number] => 14/335413 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 98 [patent_no_of_words] => 19159 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335413 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/335413
Transgenic Jul 17, 2014 Issued
Array ( [id] => 11479373 [patent_doc_number] => 09585894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Compositions comprising exemestane and novel methods of use' [patent_app_type] => utility [patent_app_number] => 14/333914 [patent_app_country] => US [patent_app_date] => 2014-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 13709 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14333914 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/333914
Compositions comprising exemestane and novel methods of use Jul 16, 2014 Issued
Array ( [id] => 11075965 [patent_doc_number] => 20160272929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'METHOD FOR CULTURING PLURIPOTENT STEM CELLS, AND FACILITY THEREFOR' [patent_app_type] => utility [patent_app_number] => 15/035879 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7659 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035879 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/035879
Facility for culturing pluripotent stem cells Jul 10, 2014 Issued
Array ( [id] => 14665507 [patent_doc_number] => 10370644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Method for making human pluripotent suspension cultures and cells derived therefrom [patent_app_type] => utility [patent_app_number] => 14/307100 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 151 [patent_figures_cnt] => 137 [patent_no_of_words] => 36084 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14307100 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/307100
Method for making human pluripotent suspension cultures and cells derived therefrom Jun 16, 2014 Issued
Array ( [id] => 11464063 [patent_doc_number] => 09580683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells' [patent_app_type] => utility [patent_app_number] => 14/302384 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6902 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302384 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/302384
ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells Jun 10, 2014 Issued
Array ( [id] => 11403012 [patent_doc_number] => 20170023550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL' [patent_app_type] => utility [patent_app_number] => 15/301641 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18781 [patent_no_of_claims] => 121 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301641 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/301641
ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL Jun 5, 2014 Abandoned
Array ( [id] => 11670349 [patent_doc_number] => 20170159070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'TRANSPOSON FOR GENOME MANIPULATION' [patent_app_type] => utility [patent_app_number] => 15/316508 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12123 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316508 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/316508
TRANSPOSON FOR GENOME MANIPULATION Jun 5, 2014 Abandoned
Array ( [id] => 9757259 [patent_doc_number] => 20140287960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'ENGINEERED LIVER TISSUES, ARRAYS THEREOF, AND METHODS OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/295226 [patent_app_country] => US [patent_app_date] => 2014-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27878 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295226 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/295226
Engineered liver tissues, arrays thereof, and methods of making the same Jun 2, 2014 Issued
Array ( [id] => 11736065 [patent_doc_number] => 09700636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT)' [patent_app_type] => utility [patent_app_number] => 14/294674 [patent_app_country] => US [patent_app_date] => 2014-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4562 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294674 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/294674
Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT) Jun 2, 2014 Issued
Array ( [id] => 15817015 [patent_doc_number] => 10633674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Mammalian gene modification method using electroporation [patent_app_type] => utility [patent_app_number] => 15/025365 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 18915 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025365 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/025365
Mammalian gene modification method using electroporation May 26, 2014 Issued
Array ( [id] => 10800631 [patent_doc_number] => 20160146788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC.' [patent_app_type] => utility [patent_app_number] => 14/893470 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17305 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893470 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/893470
METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC. May 22, 2014 Abandoned
Array ( [id] => 10743270 [patent_doc_number] => 20160089421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/892474 [patent_app_country] => US [patent_app_date] => 2014-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14211 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892474 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/892474
STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR May 20, 2014 Abandoned
Array ( [id] => 9740643 [patent_doc_number] => 20140276362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'APPARATUS AND METHOD FOR TISSUE REJUVENATION' [patent_app_type] => utility [patent_app_number] => 14/278460 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19504 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14278460 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/278460
APPARATUS AND METHOD FOR TISSUE REJUVENATION May 14, 2014 Abandoned
Array ( [id] => 10743246 [patent_doc_number] => 20160089397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES' [patent_app_type] => utility [patent_app_number] => 14/891064 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 16895 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891064 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/891064
CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES May 14, 2014 Abandoned
Array ( [id] => 10919230 [patent_doc_number] => 20140322249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'DNA VACCINES AGAINST TUMOR GROWTH AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/269998 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 16785 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269998 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/269998
DNA vaccines against tumor growth and methods of use thereof May 4, 2014 Issued
Menu